Acrivon Therapeutics, Inc.

ACRV·NASDAQ·$1.67Share Price as of 11/2·$53MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/19/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report08/12/26 8-KCurrent report06/17/26 8-KCurrent report05/13/26 8-KCurrent report03/19/26 8-KCurrent report03/02/26

Prospectuses and Registrations

S-8Registration of securities for employees08/12/26 S-8Registration of securities for employees03/19/26 S-8Registration of securities for employees05/14/25 S-8Registration of securities for employees03/28/25 S-3Shelf registration04/17/24

Proxies

DEFA14AAdditional proxy materials05/22/26 DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25

Ownership

Form 4Insider transaction10/26/26 Form 4Insider transaction10/07/26 Form 3Initial insider ownership09/02/26 Form 4Insider transaction09/02/26 Form 4Insider transaction08/27/26

Other

ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders04/25/25 EFFECTRequest for effectiveness04/29/24 ARSAnnual report to shareholders04/26/24 CORRESPCorrespondence with the SEC04/24/24